Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN)

NCT00063310 is registered in ClinicalTrials.gov with Voyager Pharmaceutical Corporation as lead sponsor.

NCT NCT00063310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00063310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN)
Lead sponsor
Voyager Pharmaceutical Corporation
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2003
Completion date
February 28, 2006
Enrollment
90
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease